Introduction
Over the previous 150 years, microsporidia were known for their impact on commercially important insects (e.g. silkworms, honey bees), fish (e.g. salmon), farm animals, and companion pets. During the past 25 years, opportunistic infections due to newly identified species of microsporidia came to be recognized in persons with AIDS, predominantly associated with wasting and diarrhea. Microsporidiosis is being recognized in both immune-competent and immune-deficient groups of people including travelers, children, organ transplant recipients, cancer patients, diabetics, and the elderly [1] .
Microsporidia are obligate, intracellular, unicellular, eukaryotic, parasitic protists related to fungi that have a unique mechanism of host cell infection. The infectious stage, or spore, contains a coiled polar tube, also called a polar filament, that everts under appropriate conditions (change in pH or osmotic pressure) and essentially injects the spore cytoplasm through the polar filament into the host cell [2 ] . Recent studies of the extent of gene compaction and reduction have suggested that the microsporidia are highly efficient parasites and excellent model systems for studies on evolution [3 ,4 ,5 ] .
Transmission is believed to occur primarily through fecal-oral routes with sources of infection including other infected humans and animals, as well as contaminated water and food [1] . Human pathogenic microsporidia such as Enterocytozoon bieneusi, Encephalitozoon hellem, and Encephalitozoon intestinalis were recently detected in municipal wastewaters in Ireland at levels that correlated with elevated temperatures peaking in April and July [6 ] . Of public health concern was the detection of spores in effluents and biosolids that are spread back into the environment to potentially infect animals and humans. Recently, a gastrointestinal foodborne outbreak due to microsporidia was attributed to contaminated cucumbers eaten by visitors to a hotel in Sweden [7 ] . Microsporidiosis may also result from direct contact to broken skin or eyes, trauma, and sexual transmission [1]. Although transplacental (vertical) transmission has been reported in nonhuman primates and a wide range of other mammals, this has not yet been documented in humans.
The purpose of this review is to provide an overview with an emphasis on reports of microsporidiosis in HIVinfected and non-HIV-infected individuals published during the previous 2 years.
Microsporidiosis and the AIDS pandemic
Prior to the AIDS pandemic, microsporidia were only rarely identified in humans. In 1985, a report was published identifying a new microsporidian, E. bieneusi, in a Haitian AIDS patient with diarrhea and wasting [8] and this species is still considered the most prevalent microsporidian species infecting HIV-infected individuals. Nearly 100 genotypes of E. bieneusi have been identified among which some infect only humans, only animals, or both humans and animals, spurring some to suggest that these genotypes may actually represent a group of species [9] . The Encephalitozoon species, E. intestinalis, E. hellem, and E. cuniculi, also are commonly identified in humans (with or without concurrent HIV infection), and a total of 14 species of microsporidia have been detected in humans (Table 1) . Prevalence rates for enteric microsporidiosis in persons with HIV infections prior to the implementation of combination antiretroviral therapy (cART) ranged from 2 to 50% based on geography, method of detection, and experience of diagnostician with an overall estimate of approximately 15% [10] . It is difficult to estimate the prevalence of systemic microsporidiosis because clinical signs are nonspecific or absent, and microsporidia are often not considered in the differential diagnoses.
Early reports of microsporidiosis in HIV-infected individuals were primarily associated with diarrhea and wasting, with E. bieneusi and E. intestinalis the predominant species infecting villus epithelial cells of the small intestine (primarily jejunum and duodenum). A cause and effect between microsporidiosis and diarrhea was reasonably well accepted but was complicated by concerns about the direct effect of HIV itself, declining immune status, and the presence of other intestinal pathogens on the intestinal mucosa. Intestinal biopsies from AIDS patients and microsporidia as the only detectable enteric pathogen exhibited partial villus atrophy and crypt hyperplasia, whereas AIDS patients with no detectable enteric pathogens did not display these changes [11] . Similar to Cryptosporidium, microsporidiosis reduced mucosal surface area and contributed to malabsorption as The Encephalitozoon species contribute to enteric disease but also have a propensity to disseminate [12] . Virtually, all organs can be infected with Encephalitozoon species or the less common species described in the Table 1 .
Among clinical syndromes associated with disseminated microsporidiosis are encephalitis, keratoconjunctivitis, sinusitis, pneumonia, myositis, peritonitis, nephritis, and hepatitis [11] .
Treatment of HIV-infected patients with cART resulted in a dramatic decline in opportunistic infections, including those due to microsporidia, in great part because of the partial restoration of cell-mediated immunity via HIV reduction. Microsporidiosis associated with diarrhea and wasting, however, continues to be problematic in areas of the world where access to cART may be limited as recently reported from Russia [13 ] , Malaysia [14] , Thailand [15, 16] , India [17] , Republic of Congo [18] , and west Ethiopia [19] . Children with concurrent HIV and E. bieneusi co-infection with diarrhea living in Uganda exhibited lower rates of weight gain that was even more pronounced when also infected with Cryptosporidium [20] . An HIV-infected newborn with microsporidia and Cryptosporidia co-infection was presumably infected from contact with the mother who had diarrhea but who refused fecal diagnostic evaluation, so it was unclear if the microsporidia infection was transmitted from breast milk, fecal contamination, or transplacentally [21 ] . In HIV-infected children living in a Thai orphanage who received cART, diarrhea due to E. bieneusi infection tended to be self-limiting, although re-infections were reported [22] . To date, only one case of microsporidiosis associated with immune reconstitution inflammatory syndrome (IRIS) has been described in an HIV patient presenting with diffusely distributed peritoneal and small bowel granulomatous nodules associated with E. bieneusi and E. intestinalis infection [23] .
Microsporidiosis in non-HIV-infected populations
The causative agent in nearly 50% of diarrhea cases is undetermined, and it is likely that microsporidia may contribute as these infections are difficult to diagnose or methods to deliberately look for microsporidia are not applied. further support inclusion of microsporidia on the NIH/ CDC biodefense category B list of pathogens of concern for water-borne and food-borne transmission.
Among immune-suppressed individuals, opportunistic infections due to microsporidia were increasingly reported in solid organ transplant recipients during the past 2 years. In a report by Champion et al. Opportunistic microsporidiosis also occurred in the elderly, in patients with malignant disease undergoing chemotherapy, and diabetics [30,31 ,32 ]. An unusual case of a vocal cord infection due to the microsporidian, Anncaliia (syn. Nosema, Brachiola) algerae was described in a 69-year-old chronic lymphocytic leukemia patient [33 ] .
A. algerae primarily infects mosquitoes and this finding suggests that vector-borne transmission of microsporidiosis is possible. A patient with diabetes and a history of myocardial infarction and hypertension was reported with a brain abscess due to Streptococcus intermedius and E. cuniculi genotype I [34 ] , and endocarditis associated with E. cuniculi was reported in a patient whose pacemaker had been replaced 3 months earlier [35] . As awareness grows and diagnostic methods are applied to deliberately examine immune-compromised individuals for microsporidia, it is expected that the number of case reports of opportunistic microsporidioses in such patients will continue to increase. Although it is probable that many of these infections resulted from exposure to contaminated water, food, and aerosols, a question remains whether these infections may be transmitted from the donor organ or whether reactivated chronic infections developed that were not detected prior to transplantation, immunosuppressive treatment, or onset of diabetes.
Enteric microsporidiosis was detected in young children below the age of 60 months, and particularly during the ages of 18-24 months when they engage in somewhat independent activities but have not yet developed good hygienic practices [22] . A longitudinal study in a Thai orphanage identified E. bieneusi in fecal specimens by PCR in 18.2% of HIV-infected children given cART treatment and 13.2% of non-HIV-infected children. Diarrhea tended to be self-limiting in both groups and infections occurred with higher incidence during the rainy month season.
The eye is an immunologically privileged site and infections due to microsporidia in HIV-infected and non-HIV-infected individuals can be manifested as punctuate keratoconjunctivitis and stromal keratitis [36 ] . Encephalitozoon species are the more common cause of microsporidial keratoconjunctivitis in HIV-infected and non-HIV-infected individuals, although cases due to Vittaforma corneae (syn. Nosema corneum) were recently reported [36 ,37 ] . Microsporidial stromal keratitis occurs less often than conjunctivitis, is typically identified in otherwise immune-competent individuals, and has been caused by infections with V. corneae, Nosema species, and Trachipleistophora species. Risk factors, in addition to HIV infection, included use of contact lenses, long-term topical corticosteroid treatment, and exposure to muddy (contaminated) water. Trauma or wounding has been associated with microsporidial stromal keratitis, and ocular infections have occurred as a consequence of systemic infection and secondary spread to the eye via contact. As reported in children, presentation with ocular infections due to microsporidia occurred more frequently during the rainy season. It has been speculated that ocular microsporidioses probably have been overlooked because this clinical presentation mimics herpes simplex virus and adenovirus infections of the eye [37 ] .
Travelers to the tropics were among the first groups of individuals without concurrent HIV infection identified with enteric microsporidiosis due to E. bieneusi or Encephalitozoon species. In these otherwise healthy immune-competent patients, diarrhea tended to be self-limiting and lasting 3-6 weeks [1, 12] . A number of these travelers were treated symptomatically with albendazole which resolved diarrhea and cleared infections due to Encephalitozoon species (i.e. spore shedding in feces ceased). Albendazole treatment, however, was not effective for and did not directly clear infections due to E. bieneusi infection. Also, E. bieneusi spore shedding continued intermittently after symptoms resolved, suggesting a transient correlation between spore shedding and diarrhea such that symptoms occurred primarily during the acute stage of infection [38] . Recently, a missionary from Mozambique with abdominal pain and frequent bowel movements because of chronic microsporidiosis was reported. Metronidazole treatment for giardiasis did not completely resolve symptoms. Subsequently, microsporidia spores consistent in size for Encephalitozoon were identified in fecal specimens, and albendazole treatment led to complete recovery [39 ] .
Unapparent microsporidia infections are also being identified. Diagnosis can be accomplished via histochemical staining of biopsies or fluids (urine, feces, and sputum) using stains such as Calcofluor White, Gram, concentrated Chromotrope, Silver, Kinyoun, or various combinations [40 ] . Greater sensitivity and specificity can be achieved using PCR-based methods and multiplex PCR also has been applied for detecting E. bieneusi, E. intestinalis, Cryptosporidium, and Cyclospora [41 ,42 ] . Serology has been used for diagnosing microsporidiosis in lab animals but has been questionable in HIV-infected patients who exhibit hypergammaglobulinemia but also are immune-deficient. Further compromising reliability of serology is the inability to culture E. bieneusi which limits the availability of antigen for testing. Recently, however, serological testing for E. bieneusi and Encephalitozoon species has been applied in both immunedeficient and immune-competent populations of people, and a relatively high seropositivity rate was detected in persons with occupational exposure to animals and otherwise healthy immune-competent individuals with no clinical signs [43 ] . A recent parasitological evaluation of fecal specimens from immune-competent Czech Republic citizens and foreign students of varying age groups identified 34-56% prevalence rates for shedding E. bieneusi and Encephalitozoon species, with the highest prevalence in the group of persons 50 years of age and older [32 ] . In addition, a 12-week longitudinal study on 15 asymptomatic but indirect immunofluorescence assay seropositive individuals in the Czech Republic demonstrated that E. bieneusi, E. cuniculi, and E. hellem spores were shed intermittently and at irregular levels in both urine and feces [44 ] . These results gave credence to the likelihood that, as demonstrated in lab animals (e.g. mice and rabbits), seropositivity in asymptomatic immune-competent people was indicative of chronic microsporidia infections that persist unless treated with drugs. Furthermore, these results suggested that among humans, several fecal specimens need to be evaluated before ruling out microsporidial infection [32 ,43 ,44 ] . The pathogenesis of microsporidiosis in otherwise healthy individuals has not been evaluated; but in laboratory animals, clinical signs often were observed during the acute stages of infection that resolved, even though the microsporidia infections persisted. In addition to concerns about persistence and reactivation, these reports raise the question about whether asymptomatic carriers of infection may transmit infections to those at risk.
Conclusion
The This study reports on a series of renal transplant recipients with intestinal microsporidia infections who were successfully treated with fumagillin to control this infection. Though approved for treatment in France, fumagillin is still not approved in the USA because of concerns about toxicity (e.g. reversible thrombocytopenia) and interaction complications with drugs used to prevent organ rejection (e.g. tacrolimus).
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